EUVIMEDEUVIMED entdecken
Open Access

Expanded Targeted-Exome Sequencing and Functional Validation Improve Molecular Diagnosis and Refine Genotype-Phenotype Correlations in Congenital Hypogonadotropic Hypogonadism

Jessica Silva Fausto, Lucas G A Ferreira, Silvia R Correa-Silva, Maria Izabel Chiamolera, Elisa Napolitano E Ferreira, Ilda Kunii, Magnus R Dias-da-Silva

Neuroendocrinology · 2025

DOI: 10.1159/000548348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuroendocrinology, 2025. Verfasst von Jessica Silva Fausto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular and Translational Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São …. Hauptthemen laut MEDLINE: Hypogonadism, Genetic Association Studies, Exome Sequencing. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Congenital hypogonadotropic hypogonadism (CHH) arises from defects in the synthesis, secretion, or action of gonadotropin-releasing hormone (GnRH), resulting in incomplete or absent pubertal development and various nonreproductive features. CHH is genetically heterogeneous, with over 50 genes implicated in its pathogenesis. This study aimed to elucidate the genetic variants of CHH in a cohort of patients from a single-center endocrinology unit.

Methods

We used a targeted next-generation sequencing panel to analyze 52 CHH-related genes in 35 patients. Functional studies validated two of the identified variants.

Results

Molecular etiology was identified in 20 of 35 (57%) patients. Among these, 12 (39%) had variants in multiple CHH-related genes, with oligogenic inheritance confirmed in two cases. Novel pathogenic variants (both single nucleotide variants and copy number variants) were identified, including ANOS1 p.Gln238* and c.318+2T>C, CHD7 p.Ser734Ilefs5 and p.Gln592Serfs16, FGFR1 p.Ala36Profs67, c.1663+5G>A, and p.Tyr210*, DMXL2 deletion (83.1 Kb), and SOX2 deletion (1.1 Mb). In total, 21 pathogenic or likely pathogenic variants across 15 CHH-related genes were detected, including ANOS1, CHD7, FGFR1, PROKR2, and others. A functional study confirmed the loss of function in the KISS1R p.Ala203Asp variant.

Conclusion

Our findings demonstrate the utility of a next-generation sequencing panel in diagnosing genetically complex conditions like CHH and underscore the role of oligogenic inheritance in its phenotypic diversity. The inclusion of genes previously associated with syndromic CHH forms such as CHARGE in the exome panel may highlight possible shared mechanisms with neurodevelopmental disorders, aiding early diagnosis, genetic counseling, and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypogonadismGenetic Association StudiesExome SequencingHumansMaleFemaleAdolescentChildYoung AdultAdultReceptor, Fibroblast Growth Factor, Type 1High-Throughput Nucleotide SequencingDNA HelicasesDNA-Binding ProteinsNerve Tissue ProteinsExtracellular Matrix Proteins

Stichwörter der Autor:innen

Congenital hypogonadotropic hypogonadismGenetic variantsKISS1RKallmann syndromeTargeted next-generation sequencing

Substanzen

FGFR1 protein, humanReceptor, Fibroblast Growth Factor, Type 1ANOS1 protein, humanCHD7 protein, humanDNA HelicasesDNA-Binding ProteinsNerve Tissue ProteinsExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Laboratory of Molecular and Translational Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Neuroendocrinology Unit, Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Developmental Endocrinology Unit, Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Laboratory of Molecular and Translational Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil, silvia.correa@unifesp.br.
  • Neuroendocrinology Unit, Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil, silvia.correa@unifesp.br.
  • Research and Development, Fleury Group, São Paulo, Brazil.

Zitieren

APA

Fausto, J. S., Ferreira, L. G. A., Correa-Silva, S. R., Chiamolera, M. I., Napolitano E Ferreira, E., Kunii, I., & Dias-da-Silva, M. R. (2025). Expanded Targeted-Exome Sequencing and Functional Validation Improve Molecular Diagnosis and Refine Genotype-Phenotype Correlations in Congenital Hypogonadotropic Hypogonadism. Neuroendocrinology. https://doi.org/10.1159/000548348

Vancouver

Fausto JS, Ferreira LGA, Correa-Silva SR, Chiamolera MI, Napolitano E Ferreira E, Kunii I, et al. Expanded Targeted-Exome Sequencing and Functional Validation Improve Molecular Diagnosis and Refine Genotype-Phenotype Correlations in Congenital Hypogonadotropic Hypogonadism. Neuroendocrinology. 2025. doi:10.1159/000548348

BibTeX
@article{Fausto2025,
  author = {Fausto, Jessica Silva and Ferreira, Lucas G A and Correa-Silva, Silvia R and Chiamolera, Maria Izabel and Napolitano E Ferreira, Elisa and Kunii, Ilda and Dias-da-Silva, Magnus R},
  title = {Expanded Targeted-Exome Sequencing and Functional Validation Improve Molecular Diagnosis and Refine Genotype-Phenotype Correlations in Congenital Hypogonadotropic Hypogonadism},
  journal = {Neuroendocrinology},
  year = {2025},
  doi = {10.1159/000548348}
}
Kostenlos starten →